MSCohi-O lenses
/ Guangdong ProCapZoom Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 09, 2025
MSCohi-O lenses attenuate corneal transplant rejection via HLA-G5 driven Treg cell expansion.
(PubMed, BMC Ophthalmol)
- No abstract available
Journal • Immunology • Ophthalmology • Transplant Rejection • Transplantation
September 23, 2025
MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd.
New P1 trial • Immunology • Sjogren's Syndrome
July 15, 2025
TLR3-overexpressing umbilical cord mesenchymal stromal cells suppress immune responses to attenuate high-risk corneal transplantation rejection.
(PubMed, Stem Cell Res Ther)
- "This study shows that the localized application of UC-MSC-coated contact lenses is capable of inhibiting rejection in high-risk corneal transplantation. TLR3-overexpressing UC-MSCs have enhanced antirejection and immunomodulatory effects. This research could offer a safer and more effective therapeutic strategy to prevent corneal transplant rejection."
IO biomarker • Journal • Immunology • Ophthalmology • Transplant Rejection • Transplantation • TLR3
1 to 3
Of
3
Go to page
1